Your browser doesn't support javascript.
loading
An ex vivo assay of XRT-induced Rad51 foci formation predicts response to PARP-inhibition in ovarian cancer.
Shah, Monjri M; Dobbin, Zachary C; Nowsheen, Somaira; Wielgos, Monica; Katre, Ashwini A; Alvarez, Ronald D; Konstantinopoulos, Panagiotis A; Yang, Eddy S; Landen, Charles N.
Afiliación
  • Shah MM; Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Dobbin ZC; Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Nowsheen S; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Wielgos M; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Katre AA; Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Alvarez RD; Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Konstantinopoulos PA; Department of Medicine, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Yang ES; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Landen CN; Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: clanden@uabmc.edu.
Gynecol Oncol ; 134(2): 331-7, 2014 Aug.
Article en En | MEDLINE | ID: mdl-24844596

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Recombinasa Rad51 / Inhibidores de Poli(ADP-Ribosa) Polimerasas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Recombinasa Rad51 / Inhibidores de Poli(ADP-Ribosa) Polimerasas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos